MEI Pharma registers resale of 32.3M shares by selling stockholders; company gets no proceeds

Filed September 5, 2025 · ~1 min read

Key Changes

• high

  The offering is entirely secondary: up to 32,309,944 shares are being registered for resale by selling stockholders, not by the company.

  The Offering verify on EDGAR →
• high

  The company will not receive any proceeds from the sale of these shares.

  The Offering verify on EDGAR →
• high

  The registered shares include 25,301,407 PIPE shares issued in a private placement that closed July 22, 2025.

  The Offering verify on EDGAR →